Marinus Pharmaceuticals Inc MRNS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/07/21 EDT
14.09UNCH (UNCH)
Volume
2,586
Close
14.09quote price arrow up+0.36 (+2.62%)
Volume
222,176
52 week range
6.04 - 20.04

...

Loading . . .
  • Open13.72
  • Day High14.11
  • Day Low13.59
  • Prev Close13.73
  • 52 Week High20.04
  • 52 Week High Date03/10/21
  • 52 Week Low6.04
  • 52 Week Low Date07/29/20

Key Stats

  • Market Cap516.12M
  • Shares Out36.63M
  • 10 Day Average Volume0.18M
  • Dividend-
  • Dividend Yield-
  • Beta1.42
  • YTD % Change15.49

KEY STATS

  • Open13.72
  • Day High14.11
  • Day Low13.59
  • Prev Close13.73
  • 52 Week High20.04
  • 52 Week High Date03/10/21
  • 52 Week Low6.04
  • 52 Week Low Date07/29/20
  • Market Cap516.12M
  • Shares Out36.63M
  • 10 Day Average Volume0.18M
  • Dividend-
  • Dividend Yield-
  • Beta1.42
  • YTD % Change15.49

RATIOS/PROFITABILITY

  • EPS (TTM)-3.05
  • P/E (TTM)-4.61
  • Fwd P/E (NTM)-7.25
  • EBITDA (MRQ)-67.604M
  • ROE (MRQ)-79.41%
  • Revenue (MRQ)1.72M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-3,927.53%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date05/13/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Marinus Pharmaceuticals Inc

There is no recent news for this security.

Latest From Our Partners

Profile

MORE
Marinus Pharmaceuticals Inc is a United States-based biopharmaceutical company. The Company offers development and commercialization of medical drugs for the treatment of serious neurological and psychiatric disorders such as epilepsy, post-traumatic stress, and fragile-x syndrome. Its clinical-stage product candidate, ganaxolone, is a modulator being developed in various dose forms, including intravenous, oral capsule and oral liquid, intended to provide more treatment...
Nicole Vitullo
Chairman
Scott Braunstein M.D.
President
Steven Pfanstiel
Chief Financial Officer
Martha Manning
Vice President
Sasha Damouni Ellis
Vice President
Address
5 Radnor Corporate Center Suite 500
100 Matsonford Rd
Radnor, PA
19087
United States

Top Peers

SYMBOLLASTCHG%CHG
OYST
Oyster Point Pharma Inc
17.78-0.06-0.34%
NLTX
Neoleukin Therapeutics Inc
11.58+0.35+3.12%
ETNB
89Bio Inc
24.17+0.06+0.25%
RAPT
Rapt Therapeutics Inc
20.46-0.48-2.29%
CMRX
Chimerix Inc
8.15-0.34-4.00%